Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides: Discovery of potent and subtype-selective antimuscarinic agents

Hiroyuki Miyachi, Hiromi Kiyota, Hideharu Uchiki, Mitsuru Segawa

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

In a study directed toward the development of new, selective agents with potential utility in the treatment of altered smooth muscle contractility and tone, for example, as seen in urinary incontinence associated with bladder muscle instability, a series of 4-(1-imidazolyl)-2,2-diphenylbutyramide derivatives was prepared. These compounds were examined for M1, M2, and M3 muscarinic receptor subtype selectivity in isolated tissue assays. The compounds that showed potency and/or selectivity in these tests were further evaluated for in vivo anticholinergic effects on various organs and tissues, including urinary bladder, salivary gland, and eye in rats. The structure-activity relationships for the series of 4-(1-imidazolyl)-2,2-diphenylbutyramide derivatives are also discussed. This study led to the identification of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutyramide (KRP-197) as a candidate drug for the treatment of urinary bladder dysfunction. Copyright (C) 1999 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)1151-1161
Number of pages11
JournalBioorganic and Medicinal Chemistry
Volume7
Issue number6
DOIs
Publication statusPublished - Jun 1999
Externally publishedYes

Fingerprint

Muscarinic Antagonists
Muscle
Urinary Bladder
Muscarinic M3 Receptors
Muscarinic M2 Receptors
Muscarinic M1 Receptors
Tissue
Derivatives
Cholinergic Antagonists
Rats
Assays
Urinary Incontinence
Structure-Activity Relationship
Salivary Glands
Smooth Muscle
Pharmaceutical Preparations
Muscles
4-(1-imidazolyl)-2,2-diphenylbutyramide
imidafenacin

Keywords

  • Antagonists
  • Anticholinergics
  • Molecular modelling/mechanics
  • Receptors

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides : Discovery of potent and subtype-selective antimuscarinic agents. / Miyachi, Hiroyuki; Kiyota, Hiromi; Uchiki, Hideharu; Segawa, Mitsuru.

In: Bioorganic and Medicinal Chemistry, Vol. 7, No. 6, 06.1999, p. 1151-1161.

Research output: Contribution to journalArticle

@article{f6a9b0f24dfa4380a7bf535d099e7c2b,
title = "Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides: Discovery of potent and subtype-selective antimuscarinic agents",
abstract = "In a study directed toward the development of new, selective agents with potential utility in the treatment of altered smooth muscle contractility and tone, for example, as seen in urinary incontinence associated with bladder muscle instability, a series of 4-(1-imidazolyl)-2,2-diphenylbutyramide derivatives was prepared. These compounds were examined for M1, M2, and M3 muscarinic receptor subtype selectivity in isolated tissue assays. The compounds that showed potency and/or selectivity in these tests were further evaluated for in vivo anticholinergic effects on various organs and tissues, including urinary bladder, salivary gland, and eye in rats. The structure-activity relationships for the series of 4-(1-imidazolyl)-2,2-diphenylbutyramide derivatives are also discussed. This study led to the identification of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutyramide (KRP-197) as a candidate drug for the treatment of urinary bladder dysfunction. Copyright (C) 1999 Elsevier Science Ltd.",
keywords = "Antagonists, Anticholinergics, Molecular modelling/mechanics, Receptors",
author = "Hiroyuki Miyachi and Hiromi Kiyota and Hideharu Uchiki and Mitsuru Segawa",
year = "1999",
month = "6",
doi = "10.1016/S0968-0896(99)00003-6",
language = "English",
volume = "7",
pages = "1151--1161",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides

T2 - Discovery of potent and subtype-selective antimuscarinic agents

AU - Miyachi, Hiroyuki

AU - Kiyota, Hiromi

AU - Uchiki, Hideharu

AU - Segawa, Mitsuru

PY - 1999/6

Y1 - 1999/6

N2 - In a study directed toward the development of new, selective agents with potential utility in the treatment of altered smooth muscle contractility and tone, for example, as seen in urinary incontinence associated with bladder muscle instability, a series of 4-(1-imidazolyl)-2,2-diphenylbutyramide derivatives was prepared. These compounds were examined for M1, M2, and M3 muscarinic receptor subtype selectivity in isolated tissue assays. The compounds that showed potency and/or selectivity in these tests were further evaluated for in vivo anticholinergic effects on various organs and tissues, including urinary bladder, salivary gland, and eye in rats. The structure-activity relationships for the series of 4-(1-imidazolyl)-2,2-diphenylbutyramide derivatives are also discussed. This study led to the identification of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutyramide (KRP-197) as a candidate drug for the treatment of urinary bladder dysfunction. Copyright (C) 1999 Elsevier Science Ltd.

AB - In a study directed toward the development of new, selective agents with potential utility in the treatment of altered smooth muscle contractility and tone, for example, as seen in urinary incontinence associated with bladder muscle instability, a series of 4-(1-imidazolyl)-2,2-diphenylbutyramide derivatives was prepared. These compounds were examined for M1, M2, and M3 muscarinic receptor subtype selectivity in isolated tissue assays. The compounds that showed potency and/or selectivity in these tests were further evaluated for in vivo anticholinergic effects on various organs and tissues, including urinary bladder, salivary gland, and eye in rats. The structure-activity relationships for the series of 4-(1-imidazolyl)-2,2-diphenylbutyramide derivatives are also discussed. This study led to the identification of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutyramide (KRP-197) as a candidate drug for the treatment of urinary bladder dysfunction. Copyright (C) 1999 Elsevier Science Ltd.

KW - Antagonists

KW - Anticholinergics

KW - Molecular modelling/mechanics

KW - Receptors

UR - http://www.scopus.com/inward/record.url?scp=0033012210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033012210&partnerID=8YFLogxK

U2 - 10.1016/S0968-0896(99)00003-6

DO - 10.1016/S0968-0896(99)00003-6

M3 - Article

C2 - 10428387

AN - SCOPUS:0033012210

VL - 7

SP - 1151

EP - 1161

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 6

ER -